Spectrum Pharmaceuticals (SPPI) sees downside action
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) sees downside action ahead of FDA action. Shares down 11%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reddit (RDDT) added to S&P 500
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- FDA: issues Emergency Use Authorization for Simparica Trio to treat new world screwworm in dogs & puppies
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
